Boston Scientific News

SmarTrend, our proprietary pattern recognition system, called a Downtrend for Boston Scientific on October 02, 2009 at $10.07. Since then, Boston Scientific has returned 17% as of today's recent price of $8.36. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREE two-week trial.

Acacia Research Corporation announced today that its Thermal Scalpel LLC subsidiary has entered into an agreement with Boston Scientific Corporation.

Main Category: Cancer / Oncology Also Included In: GastroIntestinal / Gastroenterology Boston Scientific Corporation announced that it has received 510 clearance from the U.S. Food and Drug Administration and CE Mark approval to market its WallFlex Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures caused by tumors ...

The Natick-based company is transferring the plant's work to a vacant facility in Costa Rica, where labor costs are much lower, said Frank Nero, president of the Beacon Council, Miami-Dade County's economic development agency.

Local tech veteran Jon McGrath has been named president and chief operating officer of Neograft Technologies Inc.

A UBS analyst said Wednesday that medical technology stocks are trading at attractive prices, and raised his ratings or price targets on nine of them.

When we posted on Nov. 12 about the flurry of margin calls at Boston Scientific Corp.

Medtronic, St. Jude named in study One in five patients were likely to be hospitalized for complications after heart devices and connecting wires made by Boston Scientific Corp., Medtronic Inc., and St.

TheStreet.com's stock-rating model downgraded medical-device maker Boston Scientific to "sell." The numbers : The company's third-quarter loss widened 52% to $94 million and the loss per share grew 66% to 6 cents.

Dow Jones Reprints: This copy is for your personal, non-commerical use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool on any article or visit www.djreprints.com Tables: Buyers Sellers THERE HAS BEEN A dark cloud of uncertainty hanging over medical-device businesses ...

Last year we wrote that a prominent physician from the Minneapolis Heart Institute Foundation had expressed concern about test guidelines for a next-generation heart defibrillator under development at the time by Medtronic, Inc., Boston Scientific Corporation, and St.

Boston Scientific hasn't had a fiscal year of positive GAAP earnings since it bought Guidant in April 2006.

As the pharmaceutical and biotech online editor here at the Fool, I read all kinds of opinions about companies in the sector, especially those thought to be values .

In the early days of Health Care Renewal we posted several times about allegations that Guidant hid information about defects in the implantable cardiac defibrillators the company manufactured.

NATICK,A Mass. A worldwide developer, manufacturer and marketer of medical devices announced its official sponsorship of World Diabetes Day for the second consecutive year.

Boston Scientific Corporation today announced its schedule of events at the 38th annual Global Congress for Minimally Invasive Gynecology , which runs from November 15-19 in Orlando, Florida.

Dr. Donald Baim, a pioneering cardiologist who was chief medical and scientific officer of Boston Scientific Corp., died Friday after surgery to treat a form of cancer.

Angiotech Pharmaceuticals Inc. is counting on increased sales of its Quill wound closure product line to propel future revenues, predicting it will be No.

Business software and services provider Compuware Corp. has completed its $295 million acquisition of a company that manages, tests and measures the performance of corporate Web sites and mobile applications.

Boston Scientific Corp., which employs about 5,000 in the Twin Cities, said in a regulatory filing Friday it has received a federal subpoena requesting information about contributions the company made to charities that have ties to physicians or their families.